Earlier trial showed 63 per cent reduction in prostate cancer

Citation

(2004), "Earlier trial showed 63 per cent reduction in prostate cancer", Nutrition & Food Science, Vol. 34 No. 5. https://doi.org/10.1108/nfs.2004.01734eab.002

Earlier trial showed 63 per cent reduction in prostate cancer

In an earlier trial researchers at Cornell University and the University of Arizona reported a 63 per cent reduction in the development of prostate cancer in men who had taken a 200-microgram-per-day selenium supplement for ten years compared to men who took a placebo.

Selenium is a powerful antioxidant and neutralises free radicals. It enhances the P450 enzyme which detoxifies some carcinogens. Selenium proteins themselves are also involved in the repair of damaged DNA.